Table: Stella Pharma -2025/26 parent results

Stella Pharma

13/05/2026 07:39

May 13 (Reuters)- 
          Stella Pharma Corporation 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to        NEXT   
              Mar 31, 2026    Mar 31, 2025    Mar 31, 2027      YEAR     
                 LATEST         YEAR-AGO         COMPANY       COMPANY   
                 RESULTS         RESULTS        FORECAST     H1 FORECAST 
  Sales          323 mln         961 mln          1.04                   
               (-66.4 pct)    (+256.6 pct)    (+221.0 pct)               
  Operating   loss 748 mln     loss 90 mln    loss 696 mln               
  Recurring   loss 778 mln    loss 137 mln    loss 625 mln               
  Net         loss 780 mln    loss 140 mln    loss 628 mln               
  EPS        loss 22.95 yen   loss 4.22 yen  loss 17.11 yen              
  Ann Div          NIL             NIL             NIL                   
  -Q2 Div          NIL             NIL             NIL                   
  -Q4 Div          NIL             NIL             NIL                   
  
  NOTE - Stella Pharma Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T